Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1996 Dec;51(12):1248–1252. doi: 10.1136/thx.51.12.1248

Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.

S A Evans 1, A Colville 1, A J Evans 1, A J Crisp 1, I D Johnston 1
PMCID: PMC472772  PMID: 8994524

Abstract

BACKGROUND: In the United Kingdom Mycobacterium kansasii is the most common pulmonary non-tuberculous mycobacteria to cause disease in the non-HIV positive population. METHODS: The clinical features, treatment, and outcome of 47 patients (13 women) of mean (SD) age 58 (17) years with culture positive pulmonary M kansasii infection were compared with those of 87 patients (23 women) of mean (SD) age 57 (16) years with culture positive pulmonary M tuberculosis infection by review of their clinical and laboratory records. Each patient with M kansasii infection was matched for age, sex, race and, where possible, year of diagnosis with two patients with M tuberculosis infection. RESULTS: All those with M kansasii infection were of white race. Haemoptysis was more common in patients infected with M kansasii but they were less likely to present as a result of an incidental chest radiograph or symptoms other than those due to mycobacterial infection. Patients with M kansasii were also less likely to have a history of diabetes, but the frequency of previous chest disease and tuberculosis was similar. An alcohol intake of > 14 units/week was less frequent in those with M kansasii, but there were no significant differences in drug history, past and present smoking habit, occupational exposures, social class, or marital status. Patients with M kansasii received a longer total course of antimycobacterial therapy and, in particular, extended treatment with ethambutol and rifampicin was given. There was no significant difference in outcome between pulmonary M kansasii or M tuberculosis infection. CONCLUSIONS: There are group differences between the clinical features of the two infections but, with the possible exception of diabetes and alcohol intake, these features are unlikely to be diagnostically helpful. Treatment of M kansasii infection with ethambutol, isoniazid, and rifampicin in these patients was as effective as standard regimens given to patients infected with M tuberculosis.

Full text

PDF
1248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey R. K., Wyles S., Dingley M., Hesse F., Kent G. W. The isolation of high catalase Mycobacterium kansasii from tap water. Am Rev Respir Dis. 1970 Mar;101(3):430–431. doi: 10.1164/arrd.1970.101.3.430. [DOI] [PubMed] [Google Scholar]
  2. Banks J., Hunter A. M., Campbell I. A., Jenkins P. A., Smith A. P. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax. 1983 Apr;38(4):271–274. doi: 10.1136/thx.38.4.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banks J., Jenkins P. A. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Thorax. 1987 Nov;42(11):838–842. doi: 10.1136/thx.42.11.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Banks J., Jenkins P. A., Smith A. P. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. Tubercle. 1985 Sep;66(3):197–203. doi: 10.1016/0041-3879(85)90037-6. [DOI] [PubMed] [Google Scholar]
  5. Buschard K., Röpke C., Madsbad S., Mehlsen J., Sørensen T. B., Rygaard J. Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus. J Clin Lab Immunol. 1983 Mar;10(3):127–131. [PubMed] [Google Scholar]
  6. CHAVES A. D., ROBINS A. B., ABELES H. Tuberculosis case finding among homeless men in New York City. Am Rev Respir Dis. 1961 Dec;84:900–901. doi: 10.1164/arrd.1961.84.6.900. [DOI] [PubMed] [Google Scholar]
  7. Christensen E. E., Dietz G. W., Ahn C. H., Chapman J. S., Murry R. C., Hurst G. A. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. AJR Am J Roentgenol. 1978 Dec;131(6):985–993. doi: 10.2214/ajr.131.6.985. [DOI] [PubMed] [Google Scholar]
  8. Clague H. W., el-Ansary E. H., Hopkins C. A., Roberts C. Pulmonary infection with opportunist mycobacteria on Merseyside 1974-1983. Postgrad Med J. 1986 May;62(727):363–368. doi: 10.1136/pgmj.62.727.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davies P. D. Infection with Mycobacterium kansasii. Thorax. 1994 May;49(5):435–436. doi: 10.1136/thx.49.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis. 1990 Oct;142(4):940–953. doi: 10.1164/ajrccm/142.4.940. [DOI] [PubMed] [Google Scholar]
  11. Evans A. J., Crisp A. J., Hubbard R. B., Colville A., Evans S. A., Johnston I. D. Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax. 1996 Dec;51(12):1243–1247. doi: 10.1136/thx.51.12.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Faustman D., Eisenbarth G., Daley J., Breitmeyer J. Abnormal T-lymphocyte subsets in type I diabetes. Diabetes. 1989 Nov;38(11):1462–1468. doi: 10.2337/diab.38.11.1462. [DOI] [PubMed] [Google Scholar]
  13. Hendy M., Stableforth D. The effect of established diabetes mellitus on the presentation of infiltrative pulmonary tuberculosis in the immigrant Asian community of an inner city area of the United Kingdom. Br J Dis Chest. 1983 Jan;77(1):87–90. [PubMed] [Google Scholar]
  14. MacGregor R. R. Alcohol and immune defense. JAMA. 1986 Sep 19;256(11):1474–1479. [PubMed] [Google Scholar]
  15. Maliwan N., Zvetina J. R. Pulmonary mycetoma following Mycobacterium kansasii infection. Report of seven cases. Arch Intern Med. 1985 Dec;145(12):2180–2183. [PubMed] [Google Scholar]
  16. McSwiggan D. A., Collins C. H. The isolation of M. kansasii and M. xenopi from water systems. Tubercle. 1974 Dec;55(4):291–297. doi: 10.1016/0041-3879(74)90038-5. [DOI] [PubMed] [Google Scholar]
  17. O'Brien R. J., Geiter L. J., Snider D. E., Jr The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987 May;135(5):1007–1014. doi: 10.1164/arrd.1987.135.5.1007. [DOI] [PubMed] [Google Scholar]
  18. Pang S. C. Mycobacterium kansasii infections in Western Australia (1962-1987). Respir Med. 1991 May;85(3):213–218. doi: 10.1016/s0954-6111(06)80082-x. [DOI] [PubMed] [Google Scholar]
  19. Rauscher C. R., Kerby G., Ruth W. E. A ten-year clinical experience with Mycobacterium kansasii. Chest. 1974 Jul;66(1):17–19. doi: 10.1378/chest.66.1.17. [DOI] [PubMed] [Google Scholar]
  20. Rhodes R. J., Hames G. H., Campbell M. D. The problem of alcoholism among hospitalized tuberculous patients. Report of a national questionnaire survey. Am Rev Respir Dis. 1969 Mar;99(3):440–442. doi: 10.1164/arrd.1969.99.3.440. [DOI] [PubMed] [Google Scholar]
  21. Schraufnagel D. E., Leech J. A., Pollak B. Mycobacterium kansasii: colonization and disease. Br J Dis Chest. 1986 Apr;80(2):131–137. doi: 10.1016/0007-0971(86)90033-1. [DOI] [PubMed] [Google Scholar]
  22. Steadham J. E. High-catalase strains of Mycobacterium kansasii isolated from water in Texas. J Clin Microbiol. 1980 May;11(5):496–498. doi: 10.1128/jcm.11.5.496-498.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979 Jan;119(1):107–159. doi: 10.1164/arrd.1979.119.1.107. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES